Atra stock buy or sell
Short Interest in Atara Biotherapeutics Inc (NASDAQ:ATRA ... Atara Biotherapeutics Inc (NASDAQ:ATRA) saw a significant decrease in short interest in February. As of February 14th, there was short interest totalling 9,530,000 shares, a decrease of 5.4% from the January 30th total of 10,070,000 shares. Based on an average trading volume of 645,100 shares, the short-interest ratio is presently 14.8 days. Why Shares of Atara Biotherapeutics, Inc. (ATRA) Are -8.3% ... Mar 28, 2020 · Atara Biotherapeutics, Inc. (NASDAQ:ATRA) is one of the worst performers on the stock market today. At current price of $8.84, the shares have already lost -0.8 points (-8.3% lower) from its previous close of $9.64. Should you buy or avoid them? The stock sets an active trading volume day with a reported 209585 contracts so far this session.
Sep 27, 2019 · The shares of drugmaker Atara Biotherapeutics Inc (NASDAQ:ATRA) are hurting today, following a scathing bear note from Goldman Sachs. The analyst downgraded the stock to "sell…
Nov 07, 2019 · Their average twelve-month price target is $29.88, suggesting that the stock has a possible upside of 283.50%. The high price target for ATRA is $70.00 and the low price target for ATRA is $9.00. There are currently 1 sell rating, 3 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Buy." BidaskClub Downgrades Atara Biotherapeutics (NASDAQ:ATRA ... Atara Biotherapeutics (NASDAQ:ATRA) was downgraded by stock analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Friday, BidAskClub reports. ATRA has been the topic of a number of other research reports. Cowen restated a “buy” rating on shares of Atara Biotherapeutics in a […] ATRA | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for ATARA BIOTHERAPEUTICS INC (ATRA), including profile, stock chart, recent news and events, analyst opinions, and research reports. Skip to Main Content. an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment Stock Comparison: Compare Atara Biotherapeutics, Inc ... Online Stock Comparison - Compare Atara Biotherapeutics, Inc. (ATRA) to four other stocks with NASDAQ.com's stock comparison tool.
ATRA Stock News - Fidelity
Short Interest in Atara Biotherapeutics Inc (NASDAQ:ATRA ... Atara Biotherapeutics Inc (NASDAQ:ATRA) saw a significant decrease in short interest in February. As of February 14th, there was short interest totalling 9,530,000 shares, a decrease of 5.4% from the January 30th total of 10,070,000 shares. Based on an average trading volume of 645,100 shares, the short-interest ratio is presently 14.8 days. Why Shares of Atara Biotherapeutics, Inc. (ATRA) Are -8.3% ...
Stock Comparison: Compare Atara Biotherapeutics, Inc ...
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. Atara Biotherapeutics Inc. Stock Price (ATRA) | Barron's View today's stock price, news and analysis for Atara Biotherapeutics Inc. (ATRA). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation Spotting Wide-Moat Stocks: Achieve Life Sciences (ACHV ... Mar 12, 2020 · A Look At Atara Biotherapeutics (NASDAQ:ATRA) With the previous 100-day trading volume average of 627889 shares, Atara Biotherapeutics (ATRA) recorded a trading volume of 545480 shares, as the stock started the trading session at the value of $10.77, in the end touching the price of $9.96 after dropping by -7.52%.
Spotting Wide-Moat Stocks: Achieve Life Sciences (ACHV ...
19 Feb 2020 The rating they have provided for ATRA stocks is “Sell” according to the report published on September 27, 2019. Jefferies gave “ Hold” rating 18 Jul 2019 public offering of $125,000,000 of shares of its common stock. shall not constitute an offer to sell or the solicitation of an offer to buy, nor Atara Biotherapeutics, Inc. - ATRA - Stock Price Today - Zacks Get the latest Atara Biotherapeutics, Inc. ATRA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. and a bulleted list of reasons to buy or sell the stock. It also ATRA Stock Price, Forecast & News (Atara Biotherapeutics) Researching Atara Biotherapeutics (NASDAQ:ATRA) stock? View ATRA's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell … Atara Biotherapeutics (ATRA) Upgraded to Buy: Here's Why
ATRA Institutional Buys and Sells | Atara Biotherapeutics ... ATRA institutional investor trades - Atara Biotherapeutics : a breakdown of the latest and past guru buys and sells in the stock. Home The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein